Compare Axelar (AXL) vs Immunefi (IMU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Axelar vs Immunefi — how do they compare? Axelar trades at Rp736.33 (market cap Rp883,73M, Rp70,06M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Axelar is far larger — about 32.7× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Axelar's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Axelar for 56 Days and Immunefi for 5 Days on average.
| AXL | IMU | |
|---|---|---|
Market Cap | Rp883,73M | Rp27,03M |
Volume (24h) | Rp70,06M | Rp39,91M |
Circulating Supply | 1,2B AXL | 873,4M / 10B IMU (9%) |
Typical Hold Time | 56 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Axelar (AXL) is currently trading at Rp738.59 with a market cap of Rp900.67M, showing a bearish technical signal overall. The asset is positioned near support at S1 (Rp736) with moving averages indicating strong selling pressure, though oscillators are neutral. Recent on-chain activity and developer updates show steady network growth, but trading volume remains moderate. The token's hold time of 56 days suggests some investor patience despite the bearish trend.
Outlook: Short-term bearish due to technical indicators, but neutral oscillators may offer stability. Key opportunities lie in network adoption and cross-chain utility growth. Major risks include high volatility and regulatory uncertainty in the crypto space. Investors should monitor support levels closely for potential entry points.
Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Axelar
Axelar claims to deliver “secure cross-chain communication for Web3.” The project provides a decentralized network and tools to help builders of decentralized applications (dApps) with seamless cross-chain communication through its protocol suite, tools and APIs.
Read more on AXL →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
